Venous Thromboembolism in Patients with Heart Failure: In-hospital and Chronic Use of Anti-coagulants for Prevention

Title: Venous Thromboembolism in Patients with Heart Failure: In-hospital and Chronic Use of Anti-coagulants for Prevention

Volume: 7 Issue: 1

Author(s): Nasir Shariff, Abdul Aleem, Vadim Levin, Ravi V. Desai, Sudip Nanda, Matthew W. Martinez, Stacey J. Smith and Ronald Freudenberger

Affiliation:

Keywords: Congestive heart failure, prevention, venous thromboembolism, CHRONIC ANTICOAGULATION, ORAL ANTICOAGULATION, PARENTERAL ANTICOAGULATION, Rivaroxaban, Dabigatran, Apixaban, MAGELLAN

Abstract: Heart failure (HF) is a common clinical syndrome characterized by high morbidity and frequent hospitalizations. HF is an independent and major risk factor for venous thromboembolism (VTE) and VTE occurring in patients with HF carries a worse prognosis. The present review will focus on short and long term role of anti-coagulants in prevention of venous thrombosis in HF patients. We will also be discussing the recently investigated and patented anti-coagulants which could have a role in this specific population.

Cite this article as:

Shariff Nasir, Aleem Abdul, Levin Vadim, V. Desai Ravi, Nanda Sudip, W. Martinez Matthew, J. Smith Stacey and Freudenberger Ronald, Venous Thromboembolism in Patients with Heart Failure: In-hospital and Chronic Use of Anti-coagulants for Prevention, Recent Patents on Cardiovascular Drug Discovery 2012; 7 (1) . https://dx.doi.org/10.2174/157489012799362395

DOI https://dx.doi.org/10.2174/157489012799362395	Print ISSN 2212-3962
Publisher Name Bentham Science Publisher	Online ISSN 1574-8901